Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Why Dimerix (ASX:DXB) Presented New Biomarker Data on CCR2 Activity and Kidney Disease Outcomes in FSGS

Dimerix (ASX:DXB) announced on 23 October 2026 (Sydney time) that new data supporting the biological rationale for DMX-200 in focal segmental glomerulosclerosis (FSGS) had been presented on 22 October at Kidney Week 2026 in Denver. The presentation was given by Dr Sean Eddy of …

Sonal Goyal | 23 October 2026

Why Firebrick Pharma (ASX:FRE) Has Decided to Enter US Retail Pharmacies with Its Nasodine Products

Firebrick Pharma Limited (ASX:FRE) reported for the September 2026 quarter that it decided on 29 September 2026 to enter the US retail pharmacy market with its Nasodine products. The company cited growth in online sales and its attendance at the NACDS retail trade expo …

Sonal Goyal | 23 October 2026

Pharmx Technologies Ltd (ASX:PHX) Shares Drop on the ASX: What’s Driving the Move?

Pharmx Technologies Ltd (ASX:PHX) was trading at A$0.065, down 9.72%, during the 23 October 2026 trading session, a considerably larger fall than the S&P/ASX 200 (XJO), which was at 8,760.50, down 0.37% (down 32.70 points) at 1:16 pm AEDT. Pharmx describes itself as an …

Sonal Goyal | 23 October 2026

ZOONO Group Ltd (ASX:ZNO) Share Price Drops: Key Reasons Explained

ZOONO Group Ltd (ASX:ZNO) was trading at A$0.044 during the 23 October 2026 trading session, down 12.00%. By comparison, the S&P/ASX 200 (XJO) was at 8,760.50, down 0.37% (32.70 points) at 1:16 pm AEDT, meaning ZOONO's move was far wider than the benchmark's. ZOONO …

Sonal Goyal | 23 October 2026

AVITA Medical (ASX:AVH) Is Up 246.03%: Is It Still Worth a Closer Look?

AVITA Medical, Inc. develops and sells products for wound care and skin restoration. Its commercial portfolio is led by the RECELL system, supported by Cohealyx and PermeaDerm, and it also reports international revenue. The company is headquartered in Valencia, California, and is listed on …

Sonal Goyal | 22 October 2026

Orthocell (ASX:OCC): Down 59.30% in a Year — Is the Stock Still on the Radar?

Orthocell Limited is a Perth-based regenerative medicine company. Its Remplir product is a collagen membrane used in peripheral nerve repair, sold in the United States, Australia and other markets, and the company reports unit sales, hospital and surgeon adoption and cash use alongside revenue.

Sonal Goyal | 22 October 2026

What Is Behind the Drop in Epsilon Healthcare (ASX:EPN) Shares Today?

Epsilon Healthcare Limited is an Australian-based, globally active healthcare organisation listed on the ASX under the code EPN. Its registered office and principal place ofBusinessis at 5 Goodyear Street, Southport, Queensland. The board comprises Alan Beasley as Chairman, Peter Giannopoulos as Executive Director and …

Sonal Goyal | 22 October 2026

How Are Microba Life Sciences (ASX:MAP) Shares Faring After a 10% Drop?

Microba Life Sciences is listed on the Australian Securities Exchange under the ticker MAP. The company describes itself as being at the forefront of microbiome health and human care. Its chair, Pasquale Rombola, is named as the investor contact in the latest announcement. The …

Sonal Goyal | 22 October 2026

Why Is Orthocell (ASX:OCC) Stock Down 12.5% Today?

Orthocell Limited is an ASX-listed regenerative medicine company with its registered office at Building 191, Murdoch University, 90 South Street, Murdoch, Western Australia. The company describes its focus as regenerating mobility for patients through products that repair a variety of bone and soft tissue …

Sonal Goyal | 22 October 2026

What Is Behind the Oneview Healthcare (ASX:ONE) Share Price Fall of 13%?

Oneview Healthcare PLC is listed on the Australian Securities Exchange under the ticker ONE and is domiciled in Ireland, with its registered office in Blackrock, Co. Dublin. It also has an office in Victoria, Australia.

Sonal Goyal | 22 October 2026
Support

Hi! How can we help you today?

Loading…